OpenClinica Solutions

Modern, modular & comprehensive clinical trial research toolset delivering power & ease of use throughout the study lifecycle.

two clinical researchers interacting with data on a computer screen

Automated, reusable workflows, intuitive interfaces and clear dashboards simplify and improve experience and outcomes. We deliver a flexible platform of best-in-class solutions that work beautifully together or as standalone solutions: EHR-to-EDC Integration | eSource | EDC | ePRO & eCOA | eConsent | Patient-Level Data Capture | Randomization & Supply Chain | Data Analytics

From recruitment to study lock, we've got you.

  • EHR to EDC eSource

    Auto-populate EDC & eCRFs with regulatory-grade source data from patient EHRs in real-time. Unite is a device-agnostic solution that’s proven & scalable. Loved by research staff. Valued by sponsors. Learn more

  • Electronic Data Capture

    Speed up study start with our EDC’s intuitive form builder. Maintain momentum with automated workflows & notifications, smart eCRFs, and protocol automation for participant and research scheduling. Learn more.

  • ePRO & eCOA

    Keep participants engaged, ease clinician burden and get higher-quality results earlier with anytime, anywhere, any device outcome reporting. Learn more.

  • eConsent

    Deliver an engaging consent experience to boost recruitment, retention and onboarding with total electronic consent management. Learn more.

  • Randomization & Supply Chain

    Create easy, automated workflows for total randomization and supply chain management right within eCRFs. Learn more.

  • Data Analytics

    Visualize, analyze and share key trial analytics in real-time with out-of-the-box library of reports and dashboards. Easily build and share customized insights to meet your unique trial needs. Learn more.

  • ehr-to-edc-integration-icon-3
    15,000+

    Clinical trials across 100+ countries

  • OpenClinica EDC data capture impacts over 3 million participants-icon
    3 Million+

    Participants supported

  • OpenClinica EDC data capture is trusted over 500 customers-icon
    500+

    Customers trust OpenClinica

The best way to learn about us is to have a conversation.

The OpenClinica Difference

Support for all types & phases of clinical trials

Adaptive platform, master protocol, device, umbrella, observational, interventional, digital therapeutics (DTx), plus registries and real-world evidence research are just a sampling of the types of trials we support. Our flexible framework delivers unparalleled support for trials in all types & phases of clinical research.

two female clinical researchers looking at a tablet in lab
woman with cancer using laptop

Serving all indications & therapeutic areas

Our flexible, scalable, intelligent, no-code/low-code solutions are ideal for all indications and therapeutic areas. Our customers include large-scale, multi-year adaptive platform oncology trials, extensive diabetes trials, cell and gene therapy research, biotechnology studies, cardiovascular disease research, rare disease and orphan drug development, infectious disease trials, neurology studies, mental health and psychiatry research, immunology and inflammatory disease trials, pediatrics, dermatology studies, ophthalmology research, respiratory disease trials, and regenerative medicine.

Loved by researchers

Our solutions are developed & constantly refined with the busy researcher front-of-mind. Always. We believe that gathering & analyzing study data should be effortless and that turning protocols and protocol changes into eCRFs should be a breeze. We believe technology should enable site & study teams to focus on high-value scientific research and patient-focused care.

 

female medical staff using tablet
OpenClinica Core EDC earns high praise in Everest PEAK EDC Matrix assessment

Valued by leadership

By automating and simplifying data management & analysis, site leadership can take on more studies; sponsors can get early, reliable data for better decision making, academic research organizations can do better research, CROs can gain a competitive advantage, and most importantly, people can get the therapies they need sooner.

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×